Unlocking Precision
Gene Editing with AI
At Neoclease, we're pioneering a transformative
approach to custom nuclease design.
​​​​​
Through our groundbreaking technology, we aim to redefine and accelerate the field of gene editing, ultimately improving the lives of millions.
Revolutionizing human health, one edit at a time
OUR VISION
Imagine a world where genetic disorders are a thing of the past, where diseases can be cured with pinpoint accuracy.
Our vision at Neoclease is to make this a reality. We harness the power of synthetic biology and generative AI to develop custom nucleases, gene-editing enzymes designed to target specific genes or diseases.
​
REVOLUTIONIZING
PRECISION MEDICINE
Neoclease engineers gene-specific nucleases through a GenAI model that are miniaturized, precise, and efficient for therapeutic editing in previously inaccessible to CRISPR tissues.
Our first editor targets LRRK2 in Parkinson’s with the aim of slowing or halting disease progression.
Our nucleases offer unparalleled precision and efficacy, reducing the risk of side effects and ushering in a new era of precision medicine.
​
We're not just treating symptoms; we're working towards cures.
COLLABORATION FOR IMPACT
We believe in the power of collaboration. Neoclease collaborates with industry leaders to drive innovation in gene editing technologies and therapies. By working together, we can make a profound impact on healthcare and improve the lives of patients worldwide.
Company Support
